|

R-mini-CHOP Clinical Trials

2 actively recruiting trials

Pipeline

Phase 3: 2

Top Sponsors

  • Nordic Lymphoma Group1
  • AstraZeneca1

Indications

  • Cancer2
  • Large B-cell Lymphoma1
  • DLBCL1
  • Diffuse Large B-Cell Lymphoma1

Other2 trials

A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma
Phase 3
AZD0486 1L Therapy for Elderly or Unfit Participants With LBCL
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.